# Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease

> **NCT00738179** · PHASE3 · UNKNOWN · sponsor: **Adelaide Institute for Sleep Health** · enrollment: 2500 (estimated)

## Conditions studied

- Sleep Apnea
- Cardiovascular Disease

## Interventions

- **DEVICE:** Continuous Positive Airway Pressure (CPAP)
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT00738179
- **Lead sponsor:** Adelaide Institute for Sleep Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2015-02-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00738179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00738179, "Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00738179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*